Literature DB >> 8705811

[Training in cognitive functions in neurologic rehabilitation of craniocerebral trauma].

H Friedl-Francesconi1, H Binder.   

Abstract

This study evaluates a new cognitive rehabilitation therapy for patients after severe head injury. In addition to the standard neurological rehabilitation therapy, one group was trained by the Wiener Determinationsgerät (WDT), a second group was treated by the new program REHACOM, while a third group received only conventional neurological rehabilitation therapy. The three groups each consisted of 12 patients; two groups received 20 sessions of training, each lasting 40 minutes. At the beginning as well as after the therapy a psychological test battery was applied, consisting of HAWIE, TULUC, AACHENER APHASIETEST, and BENTON-Test. They were also tested by a specific neuropsychological battery regarding hemispheric specialization. REHACOM showed significantly higher values on the HAWIE as well as on BENTON-Test than the other two groups. REHACOM also improved in right-hemispheric dimensions while WDT group did not improve in attention. Right-hemispheric training was more effective than attentional stimulation.

Entities:  

Mesh:

Year:  1996        PMID: 8705811

Source DB:  PubMed          Journal:  Z Exp Psychol        ISSN: 0949-3964


  2 in total

1.  Social skills and neurocognitive individualized training in schizophrenia: comparison with structured leisure activities.

Authors:  Silvana Galderisi; Giuseppe Piegari; Armida Mucci; Antonio Acerra; Lucio Luciano; Anna F Rabasca; Francesco Santucci; Angela Valente; Maurizio Volpe; Pasquale Mastantuono; Mario Maj
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-10-15       Impact factor: 5.270

2.  Efficacy of vision restoration therapy after optic neuritis (VISION study): study protocol for a randomized controlled trial.

Authors:  Johann Schinzel; Lina Schwarzlose; Holger Dietze; Karolina Bartusch; Susanne Weiss; Stephanie Ohlraun; Friedemann Paul; Jan Dörr
Journal:  Trials       Date:  2012-06-28       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.